"Regtect" is a drug for the treatment of alcohol addiction, which affects the central nervous system and reduces the craving for alcohol.
Manufacturer: Nippon Shinyaku Co., Ltd. (Japan).
Active ingredient: acamprosate calcium.
Form of release: 100 tablets of 333 mg.
Method of use: Adults are recommended to take 2 tablets (666 mg of the active ingredient) 3 times a day after meals.
Contraindications: individual intolerance to the drugs, renal insufficiency, pregnancy and lactation, as well as simultaneous use of other medications.
Side effects: diarrhea, drowsiness, bloating, vomiting, skin rashes (eczema, psoriasis, hives), itching, and rashes.





